Regulation of insulin release at low O 2 tensions is important to hypoxic children because of their increased reliance upon carbohydrate metabolism for energy production. We have found immunoreactive insulin (IRI) release inhibited by alpha adrenergic receptor stimulation in hypoxic puppies. Since cyclic AMP mediated insulin release is thought to relate the adrenergic receptor and its physiologic response, the effects of cyclic AMP elevation on IRI levels at low O 2 tensions were studied. Hypoxic puppies were given an analogue of cyclic AMP, dibutyryl cyclic AMP (DCAMP), to test the effects of exogenous cyclic AMP elevation and theophylline, a phosphodiesterase inhibitor, to test the effects of endogenous elevation of cyclic AMP.
In air breathing puppies (PaO 2 > 75 mm Hg), either DCAMP or theophylline infusion resulted in sustained elevations of plasma IRI and glucose. With 75 min of hypoxia alone (PaO 2 25-35 mm Hg), plasma IRI remained at baseline levels despite the development of marked hyperglycemia. In contrast, puppies receiving DCAMP or theophylline after 30 min of hypoxia were found to have significantly higher IRI levels than did the hypoxic control group (p<0.05). The IRI levels reached with DCAMP or theophylline appeared related to the concomitant glucose levels.
These observations suggest alpha adrenergic inhibition of insulin release in hypoxia is the result of reduced cyclic AMP levels.
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Aldosterone Metabolism in Cystic Fibrosis (CF). CF patients show inability to retain salt through sweat leading to serious and at times, fatal complications through cardio-vascular collapse. Aldosteronerenin system metabolism has never been accurately determined in this disorder.
Five CF patients, 13 to 21 years of age, were studied on an air-conditioned metabolic unit on constant dietary regimens with 9,109, and 240 mEq/24 h sodium intake for 8-day periods. During each 8-day period of different sodium balance, aldosterone secretion rate (ASR) and plasma renin activity were measured; the latter in both the supine and upright position.
All patients were in good sodium metabolic balance and renal electrolyte conservation was normal. On the 109 mEq sodium regimen, the mean ASR was 282 ,ug/24 h (normal: 91 ±30.4). In 4 out of 5 patients on the 240 mEq sodium regimen, the mean ASR was 205 /ig/24 h (normal: 35.9± 16.1); the 5th patient suppressed moderately to ASR 62 ,«g/24 h. On the 9 mEq sodium regimen, all 5 patients were able to increase normally to ASR 702 ^g/24 h (normal mean: 639±441). Plasma renin values were somewhat elevated on the different sodium intakes, but rose normally with the upright posture.
Conclusions: In 5 CF patients, ASR and renin values were slightly elevated, but responded normally to decreased oral sodium intake and postural changes. ASR did not suppress as expected on the high sodium intake. This state of slight hyperaldosteronism secondary to increased renin release is probably due to adaptation to frequent excessive sodium losses via the sweat and consequent extracellular volume changes. I uptake for thyroid function, and metyrapone stimulation for adrenal function. Concentrating ability was used as an index of vasopressin release. Gonadotropin was assessed by physical examination only. In 6 patients, only vasopressin and growth hormone (GH) response was studied. In 5 thyroid and adrenocortical evaluation was also obtained. Of the 11 children, 4 were of normal height for age, while 7 were below the 3rd percentile. Those children with normal height all had normal GH response. Two of them had DI with normal thyroid and adrenal function. Of the 7 children with retardation of linear growth, 6 were found to be GH deficient. The 1 child with normal GH had a strong family history of short stature. Five had DI and all were GH deficient. Thyroid studies were normal in 2 and adrenal studies in 3 of these. One child had histiocytosis of the thyroid gland with goiter and hypothyroidism. In 3 children of adolescent age with short stature, GH deficiency and DI, puberty was delayed. This study documents that histiocytosis may involve the anterior and/or posterior pituitary. An adequate clinical evaluation should include study of the anterior pituitary. of Ped., Meadowbrook Hosp., East Meadow, NY. To understand the early molecular events that lead to some of the effects of growth hormone on liver, a dose of 3 H-HGH (18 X 10 6 cpm, 60 fig) was given i.v. to hypophysectomized rats. After the injection, livers were homogenized and fractionated by centrifugation. Specific activity (cpm/mg protein) and total radioactivity expressed as percent of that in the homogenate were estimated (table). 3 H-HGH in the homogenate was estimated by precipitation with TCA, and with Na 2 SO 4 as 3 H-HGH antibody complex with and without unlabeled hormone. Up to 10 min most radioactivity was protein bound and 3 H-HGH in the homogenate was antigenically similar to the injected dose. In contrast, when 3 H-HGH was added in vitro before homogenization most radioactivity (77%) appeared in the cytoplasm and the rest distributed almost equally among the other fractions. These results indicate (1) the early rapid uptake by the particulate fractions may be of functional significance and the important initial binding sites may be mitochondria and microsomes; (2) the movement of 3 H-GH in liver cell may be from the microsomal and mitochondrial fractions into cytoplasm; (3) after 10 min 3 H-HGH is degraded or deacetylated. C. GREEN, Univ. of Pittsburgh, Univ. of Minnesota and Northwestern Univ., Depts. of Ped. In this family, two affected boys have perineal hypospadias and bifid scrotum, and two affected girls have slight clitoral enlargement with otherwise normal genitalia. All are mild 'salt-losers' with spontaneous crises occurring late (3 months and 2 years) in the boys. The girls had negative Na+ balance only when stressed by salt deprivation at ages 2 months and 4 years. All had elevated 17-ketosteroid excretion when diagnosed and, in the 2 youngest, urinary DHA > androsterone. Cortisol production and/or 17-OH-corticosteroid excretions were normal. Steroid excretion patterns showed an increase of 3/S-HSD activity with increased age, but with a persisting high excretion of ^l 5 -pregnanetriol (Zl 5 -p'triol). At 2 months, one girl excreted per 24 h: pregnanetriol (p'triol)-0.23 mg, J 5 -p'triol-1.2 mg, 17a-OH-pregnenolone-2.6 mg, 16a-OH-pregnenolone-8.2 mg, 16a-OH-DHA-5.4 mg, DHA-0.5 mg.
Her sister, at age 10 years, during withdrawal of cortisone therapy, excreted per 24 h: p'triol-24 mg, zl s -p'triol-14 mg, DHA-1.2 mg, no 16<x-OH-pregnenolone or 16a-OH-DHA. We conclude that these cases have partial 3/3-HSD deficiencies, on the basis of the inadequate fetal virilization and persistent post-natal excretion of large amounts of z1 5 -p'triol; and partial 21 -hydroxylase deficiencies, on the basis of the high p'triol excretions. The low post-natal excretion of DHA, relative to Zl 5 -p'triol and 17a-OH-pregnenolone, may be due to a late fetal appearance of the 3/3-HSD for DHA or may be due to an underactivity of the 17-20 desmolase (side-chain splitting) enzyme.
